Sumova A, Maywood E S, Selvage D, Ebling F J, Hastings M H
Department of Anatomy, University of Cambridge, UK.
Brain Res. 1996 Feb 12;709(1):88-96. doi: 10.1016/0006-8993(95)01314-8.
Single episodes of arousal of Syrian hamsters 2 h before projected activity onset (i.e., CT 10) phase-advanced their free-running circadian rhythm of wheel-running. Serial arousal once every 23 h or once every 23.5 h for 7 days caused large composite phase-advances to the wheel-running rhythm, the latter period being more effective in supporting an interval of stable entrainment. Pre-treatment of hamsters at CT 6 with the serotonergic antagonist ritanserin (1-5 mg/kg, which acts at both 5-HT2 and the putative 5-HT7 receptor, impaired the phase-advancing response to arousal at CT 10 but the drug was without effect on phase advances induced by exposure to light. Pre-treatment with a second serotonergic antagonist, ketanserin (1-5 mg/kg), which is without effect at 5-HT7 but has high affinity for 5-HT2 receptors, was also effective in attenuating the phase advancing effect of arousal at CT 10. However, neither agent was able to achieve complete blockade of the phase advances. These results are discussed in relation to in vitro and in vivo studies in the rat which have identified a role for 5-HT7 receptors in serotonin-mediated circadian entrainment.
在预计活动开始前2小时(即CT10)单次唤醒叙利亚仓鼠,使其自由运转的昼夜节律性轮转活动出现相位提前。每23小时或每23.5小时连续唤醒7天,会使轮转活动节律产生大幅的复合相位提前,后一个周期在支持稳定的同步化间隔方面更有效。在CT6时用5-羟色胺能拮抗剂利坦色林(1-5毫克/千克,作用于5-HT2和假定的5-HT7受体)预处理仓鼠,会损害其在CT10时对唤醒的相位提前反应,但该药物对光照诱导的相位提前没有影响。用第二种5-羟色胺能拮抗剂酮色林(1-5毫克/千克)预处理,该药物对5-HT7无作用,但对5-HT2受体具有高亲和力,也能有效减弱CT10时唤醒的相位提前效应。然而,两种药物都不能完全阻断相位提前。结合大鼠的体外和体内研究对这些结果进行了讨论,这些研究已确定5-HT7受体在5-羟色胺介导的昼夜节律同步化中起作用。